Wockhardt Limited (BOM:532300)
India · Delayed Price · Currency is INR 1,189.05
-9.15 (-0.76%)
At close: Mar 27, 2026
Wockhardt Market Cap
Wockhardt has a market cap or net worth of 193.28 billion as of March 27, 2026. Its market cap has decreased by -10.56% in one year.
Market Cap
193.28B
Enterprise Value
211.15B
Revenue
31.74B
Ranking
n/a
PE Ratio
878.57
Stock Price
1,189.05
Market Cap Chart
Since February 21, 2001, Wockhardt's market cap has increased from 17.40B to 193.28B, an increase of 1,010.59%. That is a compound annual growth rate of 10.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 193.28B | -17.75% |
| Dec 31, 2025 | 235.00B | 2.08% |
| Dec 31, 2024 | 230.20B | 276.45% |
| Dec 29, 2023 | 61.15B | 90.30% |
| Dec 30, 2022 | 32.13B | -29.77% |
| Dec 31, 2021 | 45.75B | -24.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pharmaceuticals | 382.72B |
| J. B. Chemicals & Pharmaceuticals | 330.39B |
| AstraZeneca Pharma India | 198.65B |
| Granules India | 154.44B |
| Jubilant Pharmova | 133.73B |
| Rubicon Research | 126.50B |
| Caplin Point Laboratories | 118.37B |
| CORONA Remedies | 96.72B |